Eagle Strategies’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,735
| Closed | -$376K | – | 214 |
|
|
2024
Q4 | $376K | Sell |
5,735
-3,336
| -37% | -$219K | 0.07% | 157 |
|
|
2024
Q3 | $707K | Sell |
9,071
-1,139
| -11% | -$88.7K | 0.13% | 111 |
|
|
2024
Q2 | $796K | Buy |
+10,210
| New | +$796K | 0.15% | 106 |
|
|
2024
Q1 | – | Sell |
-9,041
| Closed | -$609K | – | 270 |
|
|
2023
Q4 | $609K | Buy |
9,041
+29
| +0.3% | +$1.95K | 0.13% | 110 |
|
|
2023
Q3 | $610K | Buy |
9,012
+1,842
| +26% | +$125K | 0.15% | 106 |
|
|
2023
Q2 | $513K | Buy |
7,170
+229
| +3% | +$16.4K | 0.12% | 116 |
|
|
2023
Q1 | $482K | Buy |
6,941
+817
| +13% | +$56.7K | 0.12% | 113 |
|
|
2022
Q4 | $415K | Buy |
6,124
+1,155
| +23% | +$78.3K | 0.12% | 109 |
|
|
2022
Q3 | $273K | Buy |
+4,969
| New | +$273K | 0.14% | 84 |
|